TruWealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
TruWealth Advisors's LLY Position: Q1 2026 in Review
TruWealth Advisors increased its Eli Lilly (LLY) stake by 1.5% in Q1 2026, buying an estimated $533K and bringing the position to 35,900 shares worth $33M. The position accounts for 1.59% of the portfolio, ranked #21.
TruWealth Advisors first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $38M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- TruWealth Advisors held 35,900 shares of Eli Lilly worth $33M as of Q1 2026.
- TruWealth Advisors bought 526 Eli Lilly shares in Q1 2026, an estimated $533K.
- Eli Lilly made up 1.59% of TruWealth Advisors's portfolio in Q1 2026, its #21 holding.
- TruWealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
- TruWealth Advisors's Eli Lilly position peaked at $38M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on TruWealth Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.